Working… Menu

A Study of APG-115 in Patients With Salivary Gland Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03781986
Recruitment Status : Recruiting
First Posted : December 20, 2018
Last Update Posted : May 28, 2021
University of Michigan
Information provided by (Responsible Party):
Ascentage Pharma Group Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 15, 2022
Estimated Study Completion Date : December 15, 2022